CN103609526B - The application of mitochondrial protein translation factor Guf1 in male sterile research - Google Patents
The application of mitochondrial protein translation factor Guf1 in male sterile research Download PDFInfo
- Publication number
- CN103609526B CN103609526B CN201310485227.5A CN201310485227A CN103609526B CN 103609526 B CN103609526 B CN 103609526B CN 201310485227 A CN201310485227 A CN 201310485227A CN 103609526 B CN103609526 B CN 103609526B
- Authority
- CN
- China
- Prior art keywords
- guf1
- mitochondrial
- gene
- knockout
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000022886 mitochondrial translation Effects 0.000 title description 8
- 238000011160 research Methods 0.000 title description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 76
- 238000000034 method Methods 0.000 claims description 26
- 241000124008 Mammalia Species 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 230000002159 abnormal effect Effects 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 4
- 208000007466 Male Infertility Diseases 0.000 abstract description 10
- 230000021595 spermatogenesis Effects 0.000 abstract description 10
- 206010021929 Infertility male Diseases 0.000 abstract description 6
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000010172 mouse model Methods 0.000 abstract description 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 46
- 210000001550 testis Anatomy 0.000 description 40
- 238000011813 knockout mouse model Methods 0.000 description 33
- 230000000694 effects Effects 0.000 description 25
- 210000000918 epididymis Anatomy 0.000 description 25
- 201000010063 epididymitis Diseases 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 23
- 230000002438 mitochondrial effect Effects 0.000 description 23
- 239000000499 gel Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 17
- 210000002216 heart Anatomy 0.000 description 15
- 210000003470 mitochondria Anatomy 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 238000001262 western blot Methods 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 230000019100 sperm motility Effects 0.000 description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 108020005196 Mitochondrial DNA Proteins 0.000 description 8
- 238000000055 blue native polyacrylamide gel electrophoresis Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 7
- 230000008811 mitochondrial respiratory chain Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 108700024394 Exon Proteins 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 239000006180 TBST buffer Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 238000007400 DNA extraction Methods 0.000 description 5
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 5
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000030498 cytoplasmic translation Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 210000001671 embryonic stem cell Anatomy 0.000 description 5
- 230000001850 reproductive effect Effects 0.000 description 5
- 230000019491 signal transduction Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 230000006705 mitochondrial oxidative phosphorylation Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 238000011740 C57BL/6 mouse Methods 0.000 description 3
- 101150018198 COX1 gene Proteins 0.000 description 3
- 102100025287 Cytochrome b Human genes 0.000 description 3
- 108010075028 Cytochromes b Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 3
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 3
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 3
- 108091093105 Nuclear DNA Proteins 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 210000002459 blastocyst Anatomy 0.000 description 3
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 230000037149 energy metabolism Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000003209 gene knockout Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 108010007425 oligomycin sensitivity conferring protein Proteins 0.000 description 3
- 230000010627 oxidative phosphorylation Effects 0.000 description 3
- 238000010827 pathological analysis Methods 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 101100275424 Danio rerio mt-co1 gene Proteins 0.000 description 2
- 101100275428 Dictyostelium discoideum cox1/2 gene Proteins 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 101100284131 Homo sapiens GUF1 gene Proteins 0.000 description 2
- 101001023513 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000714177 Murine leukemia virus Species 0.000 description 2
- 102100035383 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial Human genes 0.000 description 2
- 101150062589 PTGS1 gene Proteins 0.000 description 2
- 101150000187 PTGS2 gene Proteins 0.000 description 2
- 102000008153 Peptide Elongation Factor Tu Human genes 0.000 description 2
- 108010049977 Peptide Elongation Factor Tu Proteins 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000004898 mitochondrial function Effects 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000035806 respiratory chain Effects 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000002702 ribosome display Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000002381 testicular Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VONNHDXCCQVFQI-UHFFFAOYSA-N 1-methylphenazin-10-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(C)=CC=CC3=[NH+]C2=C1 VONNHDXCCQVFQI-UHFFFAOYSA-N 0.000 description 1
- YHVQIDWAIRCSOQ-UHFFFAOYSA-N 1-nitrotetrazol-2-ium chloride Chemical compound [Cl-].[O-][N+](=O)N1C=[NH+]N=N1 YHVQIDWAIRCSOQ-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 102100021921 ATP synthase subunit a Human genes 0.000 description 1
- 102100027573 ATP synthase subunit alpha, mitochondrial Human genes 0.000 description 1
- 206010067162 Asthenospermia Diseases 0.000 description 1
- 208000007799 Asthenozoospermia Diseases 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101150001086 COB gene Proteins 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 101000678286 Danio rerio Eukaryotic translation initiation factor 4E-binding protein 3-like Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 101000800913 Dictyostelium discoideum Eukaryotic translation initiation factor 4E-1A-binding protein homolog Proteins 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 101000800906 Drosophila melanogaster Eukaryotic translation initiation factor 4E-binding protein Proteins 0.000 description 1
- 102000015782 Electron Transport Complex III Human genes 0.000 description 1
- 108010024882 Electron Transport Complex III Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 101000753741 Homo sapiens ATP synthase subunit a Proteins 0.000 description 1
- 101000936262 Homo sapiens ATP synthase subunit alpha, mitochondrial Proteins 0.000 description 1
- 101000936965 Homo sapiens ATP synthase-coupling factor 6, mitochondrial Proteins 0.000 description 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 description 1
- 101000601568 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Proteins 0.000 description 1
- 101001128687 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial Proteins 0.000 description 1
- 101000979227 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Proteins 0.000 description 1
- 101000604411 Homo sapiens NADH-ubiquinone oxidoreductase chain 1 Proteins 0.000 description 1
- 101000632623 Homo sapiens NADH-ubiquinone oxidoreductase chain 6 Proteins 0.000 description 1
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 101150053771 MT-CYB gene Proteins 0.000 description 1
- 108700036248 MT-RNR1 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 102100037524 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Human genes 0.000 description 1
- 102100023212 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Human genes 0.000 description 1
- 102100028386 NADH-ubiquinone oxidoreductase chain 6 Human genes 0.000 description 1
- 241001045988 Neogene Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 229920001774 Perfluoroether Polymers 0.000 description 1
- 229940122907 Phosphatase inhibitor Drugs 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 101150006264 ctb-1 gene Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 102000050479 human NDUFS3 Human genes 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007758 mating behavior Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 101150088166 mt:Cyt-b gene Proteins 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 101150091879 neo gene Proteins 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000004708 ribosome subunit Anatomy 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 210000001812 small ribosome subunit Anatomy 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 231100000469 sperm hypomotility Toxicity 0.000 description 1
- 238000003879 sperm preservation Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供敲除Guf1基因的模式生物小鼠在研究雄性不育机理中的用途,更具体地,本发明提供针对Guf1基因敲除的小鼠模型在研究人类雄性生殖、精子发生过程和雄性不育机理和治疗中的用途,将有可能成为诊断雄性不育的一种诊断方法。The present invention provides the use of a model organism mouse that knocks out the Guf1 gene in the study of the mechanism of male sterility. More specifically, the invention provides a mouse model for the knockout of the Guf1 gene in the study of human male reproduction, spermatogenesis and male infertility. It may become a diagnostic method for diagnosing male infertility.
Description
技术领域technical field
本发明涉及线粒体蛋白质翻译因子Guf1在雄性生殖研究中的应用。具体地,本发明提供敲除Guf1基因的模式生物小鼠在研究雄性不育过程中的用途,更具体地,本发明提供针对Guf1基因敲除的小鼠模型在研究人类雄性生殖、精子发生过程和雄性不育机理和治疗中的用途。The invention relates to the application of the mitochondrial protein translation factor Guf1 in the research of male reproduction. Specifically, the present invention provides the use of a model organism mouse that knocks out the Guf1 gene in the study of male sterility. More specifically, the present invention provides a mouse model for the knockout of the Guf1 gene in the study of human male reproduction and spermatogenesis. and uses in the mechanisms and treatment of male infertility.
背景技术Background technique
目前,全球约有15%已婚夫妇受到不孕不育的困扰,而在男性不育中弱精子症占19%,已成为影响男性生育力的常见病因。精子运动所需能量主要来自线粒体呼吸链的氧化磷酸化。如果氧化磷酸化功能异常,酶活性或表达量改变及线粒体DNA的变异等均可能导致线粒体能量合成障碍,降低精子活力。1955年,Hoffman-Berling最早证明ATP是精子尾部运动的能量来源,所以线粒体的结构和功能状态是评价精子质量的重要指标之一。近年来线粒体结构和功能异常与精子活力低下的相关性已引起关注。At present, about 15% of married couples in the world suffer from infertility, and asthenozoospermia accounts for 19% of male infertility, which has become a common cause of male fertility. The energy required for sperm motility mainly comes from the oxidative phosphorylation of the mitochondrial respiratory chain. If the function of oxidative phosphorylation is abnormal, the change of enzyme activity or expression level and the variation of mitochondrial DNA may lead to mitochondrial energy synthesis disorder and reduce sperm motility. In 1955, Hoffman-Berling was the first to prove that ATP is the energy source for sperm tail movement, so the structural and functional status of mitochondria is one of the important indicators for evaluating sperm quality. The correlation of mitochondrial structural and functional abnormalities with low sperm motility has attracted attention in recent years.
线粒体是细胞进行有氧氧化的主要细胞器,细胞的各项生命活动几乎都是由线粒体氧化磷酸化提供能量,而精子的运动需要大量的能量供应,因此精子线粒体呼吸链的氧化磷酸化功能对维持精子正常活力具有至关重要的作用,若其功能异常可能直接影响能量的产生与传递,导致精子运动障碍。目前,国内外对线粒体呼吸功能和呼吸链能量代谢的研究主要集中在一些高耗氧、能量需求大的组织器官,如肝脏组织、脑组织、心肌组织等,这些高耗氧组织线粒体能量代谢障碍会引起膜电位下降,ATP生成大大减少,影响组织器官的功能。而维持精子正常运动需要大量的能量供给,因此对精子线粒体呼吸功能和呼吸链能量代谢的研究就具有重要的意义。Mitochondria are the main organelles for cells to carry out aerobic oxidation. Almost all life activities of cells are powered by mitochondrial oxidative phosphorylation, and the movement of sperm requires a large amount of energy supply. Therefore, the oxidative phosphorylation function of sperm mitochondrial respiratory chain is important for maintaining The normal motility of sperm plays a vital role. If its function is abnormal, it may directly affect the production and transmission of energy, resulting in sperm motility disorders. At present, research on mitochondrial respiratory function and respiratory chain energy metabolism at home and abroad is mainly focused on some tissues and organs with high oxygen consumption and high energy demand, such as liver tissue, brain tissue, myocardial tissue, etc. Mitochondrial energy metabolism disorders in these high oxygen consumption tissues It will cause a decrease in membrane potential, greatly reduce ATP production, and affect the function of tissues and organs. A large amount of energy supply is required to maintain the normal movement of sperm, so the research on the respiratory function of sperm mitochondria and the energy metabolism of the respiratory chain is of great significance.
LepA作为原核细胞蛋白质翻译延伸因子可以与核糖体结合引发tRNA的反向转运,在体外能够增加蛋白质翻译的保真性。lepA的真核细胞同源蛋白Guf1蛋白是非常保守的定位于线粒体基质的蛋白,有研究说明Guf1蛋白突变的酵母细胞在低温条件下线粒体蛋白质合成速率减慢,温度升高线粒体细胞色素c氧化酶活性降低,从而表明Guf1蛋白是线粒体蛋白质合成过程中重要的保真因子。因此Guf1蛋白在高等动物体内的功能研究尤其重要。As a prokaryotic protein translation elongation factor, LepA can bind to ribosomes to trigger the reverse transport of tRNA, which can increase the fidelity of protein translation in vitro. The eukaryotic homologous protein Guf1 protein of lepA is a very conserved protein located in the mitochondrial matrix. Studies have shown that the mitochondrial protein synthesis rate in yeast cells with Guf1 protein mutations slows down under low temperature conditions, and mitochondrial cytochrome c oxidase is elevated when the temperature rises. activity was reduced, thereby indicating that the Guf1 protein is an important fidelity factor during mitochondrial protein synthesis. Therefore, the functional research of Guf1 protein in higher animals is particularly important.
发明内容Contents of the invention
我们的研究发现Guf1蛋白对于小鼠精子生成有重要意义。Guf1蛋白敲除导致小鼠精子发生过程出现障碍,精子数目显著减少,精子运动能力下降,进一步的研究发现这与睾丸的线粒体氧化磷酸化功能缺陷有关。Guf1蛋白引起线粒体蛋白质翻译加速但是翻译产物保真性差导致其降解加速有可能是线粒体氧化磷酸化功能障碍的一个重要原因。Our study found that Guf1 protein is important for mouse spermatogenesis. Knockout of Guf1 protein led to obstacles in the process of spermatogenesis in mice, a significant decrease in the number of sperm, and decreased sperm motility. Further research found that this was related to the defect of mitochondrial oxidative phosphorylation in the testis. Guf1 protein causes accelerated translation of mitochondrial proteins, but the poor fidelity of translation products leads to accelerated degradation, which may be an important reason for mitochondrial oxidative phosphorylation dysfunction.
我们首次发现在模式生物小鼠中Guf1蛋白对雄性生殖线粒体功能具有重要的调控作用。Guf1蛋白编码基因的敲除可以使得小鼠生精障碍,严重影响小鼠的精子发生和成熟,为研究雄性生殖的机理和治疗提供了重要的靶点。We found for the first time that Guf1 protein plays an important role in regulating the function of male reproductive mitochondria in the model organism mouse. Knockout of the gene encoding Guf1 protein can cause spermatogenesis disorder in mice, seriously affect the spermatogenesis and maturation of mice, and provide an important target for the study of the mechanism and treatment of male reproduction.
更具体地,本发明提供以下各项:More specifically, the present invention provides the following:
1.一种获得非人雄性不育哺乳动物的方法,所述方法包括培育Guf1基因被敲除的所述哺乳动物的雄性。CLAIMS 1. A method of obtaining a non-human male sterile mammal, said method comprising breeding males of said mammal in which the Guf1 gene has been knocked out.
2.根据1所述的方法,其中所述哺乳动物是小鼠,所述Guf1基因的序列如SEQ ID NO:1所示。2. The method according to 1, wherein the mammal is a mouse, and the sequence of the Guf1 gene is as shown in SEQ ID NO:1.
3.一种致使非人雄性哺乳动物不育的方法,所述方法包括使所述雄性哺乳动物的Guf1基因表达异常。3. A method of rendering sterile a non-human male mammal, said method comprising aberrantly expressing the Guf1 gene in said male mammal.
4.根据3所述的方法,其中所述哺乳动物是小鼠,所述Guf1基因的序列如SEQ ID NO:1所示。4. The method according to 3, wherein the mammal is a mouse, and the sequence of the Guf1 gene is as shown in SEQ ID NO:1.
5.Guf1基因作为致使非人雄性哺乳动物不育的靶点的用途。5. Use of the Guf1 gene as a target for rendering sterile a non-human male mammal.
6.根据5所述的用途,其中所述哺乳动物是小鼠,所述Guf1基因的序列如SEQ ID NO:1所示。6. purposes according to 5, wherein said mammal is mouse, and the sequence of described Guf1 gene is as shown in SEQ ID NO:1.
7.用于检测哺乳动物的Guf1基因表达异常的试剂在制备用于检测所述哺乳动物的雄性不育的诊断剂中的用途。7. Use of a reagent for detecting abnormal expression of Guf1 gene in a mammal in the preparation of a diagnostic agent for detecting male sterility in the mammal.
8.一种用于诊断雄性哺乳动物不育的试剂盒,所述试剂盒包含用于检测所述哺乳动物的Guf1基因异常的试剂。8. A kit for diagnosing infertility in a male mammal, said kit comprising a reagent for detecting abnormality of the Guf1 gene in said mammal.
附图说明Description of drawings
图1:Guf1基因敲除的策略及PCR、蛋白免疫印迹检测;Figure 1: Guf1 gene knockout strategy and PCR, Western blot detection;
图2:Guf1敲除的引起的雄性不育病理学分析;Figure 2: Pathological analysis of male sterility caused by Guf1 knockout;
图3:Guf1敲除增加精细胞凋亡,影响精子发生过程;Figure 3: Guf1 knockout increases sperm cell apoptosis and affects spermatogenesis;
图4:Guf1敲除小鼠的睾丸和精子线粒体的透射电镜观察;Figure 4: Transmission electron microscope observation of testes and sperm mitochondria of Guf1 knockout mice;
图5:Guf1蛋白对线粒体呼吸链复合物功能的影响;Figure 5: Effect of Guf1 protein on the function of mitochondrial respiratory chain complexes;
图6:Guf1敲除对线粒体呼吸链复合物亚基蛋白的影响;Figure 6: The effect of Guf1 knockout on mitochondrial respiratory chain complex subunit proteins;
图7:Guf1敲除引起胞质翻译降低和mTOR信号通路降低;Figure 7: Guf1 knockout causes decreased cytoplasmic translation and decreased mTOR signaling pathway;
图8:Guf1蛋白敲除对线粒体拷贝,转录和翻译的影响。Figure 8: Effects of Guf1 protein knockout on mitochondrial copying, transcription and translation.
图9:人精子的保存及其基因组DNA的提取。Figure 9: Preservation of human spermatozoa and extraction of their genomic DNA.
具体实施方式Detailed ways
实施例1、Guf1基因敲除的策略及PCR、蛋白免疫印迹检测。Example 1, Guf1 gene knockout strategy and PCR, Western blot detection.
为了研究Guf1蛋白在高等生物中的功能及其突变会对机体产生哪些影响。我们选择小鼠这种模式生物,运用基因打靶技术将Guf1蛋白进行敲除,并运用PCR和蛋白免疫印迹的方法对敲除的效率进行评价。图1为Guf1蛋白敲除的策略以及PCR和蛋白免疫印迹检测敲除效率。图1A表明Guf1的敲除策略图1B代表PCR鉴定的Guf1基因敲除小鼠基因型。图1B代表western blot检测Guf1在小鼠组织中的敲除效率。结果表明Guf1蛋白量在睾丸中显著减少,进一步证明该蛋白在小鼠中被剔除掉。In order to study the function of Guf1 protein in higher organisms and what impact its mutation will have on the body. We chose mice as a model organism, used gene targeting technology to knock out Guf1 protein, and used PCR and Western blot methods to evaluate the knockout efficiency. Figure 1 shows the strategy for knocking out Guf1 protein and the knockout efficiency detected by PCR and Western blot. Figure 1A shows the knockout strategy of Guf1 and Figure 1B represents the genotypes of Guf1 knockout mice identified by PCR. Figure 1B represents the knockout efficiency of Guf1 in mouse tissues detected by western blot. The results showed that the amount of Guf1 protein was significantly reduced in the testis, further evidence that the protein was knocked out in mice.
具体方法:specific method:
Guf1基因敲除小鼠的获得:Obtaining Guf1 knockout mice:
Guf1打靶载体的构建:从含有鼠Guf1基因(Guf1基因的核酸序列如SEQ.ID.NO.1所示)的129BAC(bMQ-420K22)克隆(购自Welcome TrustSanger Institute)中获得Guf1基因,如图1A所示。在该基因第二个至第八个外显子两侧加入loxp位点(其序列为GAATTCCTGCAGCCCAATTCCGATC),同时在外显子8和外显子9之间加入新霉素抗性基因(neo基因,序列如SEQ ID NO.2所示)进行下一步的筛选。打靶载体的序列如SEQ ID NO.3所示。Construction of the Guf1 targeting vector: the Guf1 gene was obtained from the 129BAC (bMQ-420K22) clone (purchased from Welcome Trust Sanger Institute) containing the mouse Guf1 gene (the nucleotide sequence of the Guf1 gene is shown in SEQ.ID.NO.1), as shown in the figure 1A. The loxp site (the sequence is GAATTCCTGCAGCCCAATTCCGATC) is added on both sides of the second to the eighth exon of the gene, and the neomycin resistance gene (neo gene, sequence Shown in SEQ ID NO.2) carry out the screening of next step. The sequence of the targeting vector is shown in SEQ ID NO.3.
胚胎干细胞阶段:打靶载体构建完成后,中体打靶质粒(约需准备100ug)电转入同源的胚胎干细胞鼠129细胞(购自南京生物医药研究院)中,使打靶载体上的Guf1基因与胚胎干细胞基因组发生同源重组,即打靶载体上Guf1外显子1和外显子8与胚胎干细胞Guf1基因组上的相同序列进行交换,进而将Guf1的外显子2至外显子8敲除。通过G418和丙氧鸟苷正负筛选获得重组胚胎干细胞克隆,并进行PCR和southernblot鉴定。Embryonic stem cell stage: After the construction of the targeting vector is completed, the midbody targeting plasmid (about 100ug needs to be prepared) is electrotransferred into homologous embryonic stem cell mouse 129 cells (purchased from Nanjing Institute of Biomedicine), so that the Guf1 gene on the targeting vector and the Homologous recombination occurs in the genome of embryonic stem cells, that is, exon 1 and exon 8 of Guf1 on the targeting vector are exchanged with the same sequence on the genome of Guf1 in embryonic stem cells, and then exon 2 to exon 8 of Guf1 are knocked out. Recombinant embryonic stem cell clones were obtained by positive and negative screening with G418 and guanosine, and identified by PCR and southern blot.
囊胚注射阶段:扩增正确中靶的ES cell克隆,显微注射到C57BL/6小鼠(南京生物医药研究院)的囊胚中,并将此囊胚移植到代孕母鼠C57BL/6(南京生物医药研究院)子宫内,产出8只雄性和2只雌性嵌合鼠。7只雄性嵌合鼠与C57BL6小鼠杂交,生出20只杂合子小鼠(Guf1flox/+)。杂合子小鼠Guf1flox/+雌雄合笼,产生后代,PCR鉴定获得Guf1flox/fox小鼠,与EIIa-cre小鼠(军事医学科学院)进行交配,获得Guf1敲除型和杂合小鼠。Blastocyst injection stage: amplify the correctly targeted ES cell clones, microinject into blastocysts of C57BL/6 mice (Nanjing Institute of Biomedicine), and transplant the blastocysts into surrogate mother mice C57BL/6 ( Nanjing Institute of Biomedicine) in utero, produced 8 male and 2 female chimeric mice. Seven male chimeric mice were crossed with C57BL6 mice to give birth to 20 heterozygous mice (Guf1 flox /+ ). Heterozygous mice Guf1 flox /+ were housed together with males and females to produce offspring. Guf1 flox /fox mice were identified by PCR and mated with EIIa-cre mice (Academy of Military Medical Sciences) to obtain Guf1 knockout and heterozygous mice.
剪取和消化鼠尾:将Guf1基因杂合小鼠合笼,新生野生,杂合和敲除型小鼠出生至18天左右时,离乳,分笼,准备好灭菌的剪刀、镊子、EP管,酒精棉球。从新生小鼠尾部末梢减去0.5cm左右的一段,放入EP管中。配制鼠尾消化液(20mM Tris-HCl,5mM EDTA,0.4M氯化钠,1% SDS,400μg/ml蛋白酶K),取400μl加入到EP管中,55度消化过夜。Cutting and digesting the mouse tail: put the Guf1 gene heterozygous mice in the same cage, and when the newborn wild, heterozygous and knockout mice are born to about 18 days old, wean the milk, separate the cages, and prepare sterilized scissors, tweezers, EP tube, alcohol cotton ball. Subtract a section about 0.5 cm from the end of the tail of the newborn mouse and put it into the EP tube. Prepare rat tail digestion solution (20mM Tris-HCl, 5mM EDTA, 0.4M NaCl, 1% SDS, 400μg/ml proteinase K), add 400μl to EP tube, and digest overnight at 55°C.
提取小鼠基因组:将小鼠消化液11000rpm离心5分钟,将上清倒入到一新的EP管中,加入200μl饱和氯化钠,上下晃动200次,冰上放置10分钟,14000rpm离心10分钟。将上清倒入至一新EP管中,加入800μl无水乙醇,14000rpm离心5分钟,弃上清,沉淀DNA室温晾干后,加入50μl双蒸水。Extract the mouse genome: centrifuge the mouse digestive solution at 11,000 rpm for 5 minutes, pour the supernatant into a new EP tube, add 200 μl saturated sodium chloride, shake up and down 200 times, place on ice for 10 minutes, and centrifuge at 14,000 rpm for 10 minutes . Pour the supernatant into a new EP tube, add 800 μl of absolute ethanol, centrifuge at 14,000 rpm for 5 minutes, discard the supernatant, and dry the precipitated DNA at room temperature, then add 50 μl of double distilled water.
PCR鉴定:合成PCR鉴定引物(上海生工合成),引物序列如下:PCR identification: Synthetic PCR identification primers (Shanghai Sangong Synthetic), the primer sequence is as follows:
Loxpt F2:5’TTTGTCCTAAATGCGTGGTG 3’Loxpt F2: 5'TTTGTCCTAAATGCGTGGTG 3'
Loxpt R2:5’CCCGCTCCCTAATAAAGATG 3’Loxpt R2: 5'CCCGCTCCCTAATAAAGATG 3'
Frtt R2:5’CGATCCCTGTACTCAAGACC 3’Frtt R2: 5'CGATCCCTGTACTCAAGACC 3'
反应体系如下:The reaction system is as follows:
2x Taq mix:10μl2x Taq mix: 10μl
Loxpt F2:0.5μlLoxpt F2: 0.5 μl
Loxpt R2(Frtt R2):0.5μlLoxpt R2 (Frtt R2): 0.5μl
基因组DNA:1.5μlGenomic DNA: 1.5 μl
RT-PCR扩增条件:变性-95度,5分钟;退火-60度,45秒;延伸-72度,1分钟;循环次数:30次;最后延伸条件-72度,10分钟。PCR样品进行琼脂糖胶电泳(胶浓度:1%)。RT-PCR amplification conditions: denaturation -95 degrees, 5 minutes; annealing -60 degrees, 45 seconds; extension -72 degrees, 1 minute; number of cycles: 30 times; final extension conditions -72 degrees, 10 minutes. PCR samples were subjected to agarose gel electrophoresis (gel concentration: 1%).
蛋白免疫印迹:将交配合笼PCR鉴定获得的6-8周龄野生型和Guf1基因敲除小鼠断颈处死,取出心脏和睾丸组织,PBS漂洗。加入RIPA裂解液1ml,放入组织研磨器研磨,匀浆液冰上放置30分钟,12000rpm离心30分钟,上清用BCA试剂盒测定蛋白浓度。Western blotting: 6-8 week-old wild-type and Guf1 knockout mice obtained by PCR identification of mating cages were killed by neck dislocation, heart and testis tissues were taken out, and rinsed with PBS. Add 1ml of RIPA lysate, grind in a tissue grinder, place the homogenate on ice for 30 minutes, centrifuge at 12000rpm for 30 minutes, and use the BCA kit to measure the protein concentration of the supernatant.
配制15% SDS-PAGE胶,将已经测好蛋白浓度的样品,加上一定体积的上样缓冲液,95度加热15分钟,取50μg蛋白加入到15% SDS-PAGE胶中,100v恒压,跑3小时左右。Prepare 15% SDS-PAGE gel, add a certain volume of sample buffer to the sample whose protein concentration has been measured, heat at 95 degrees for 15 minutes, take 50 μg of protein and add it to 15% SDS-PAGE gel, 100v constant pressure, Run for about 3 hours.
将胶上的蛋白样品转移到PVDF膜上,5%脱脂奶粉封闭1小时,然后加入1:1000稀释的抗Guf1抗体(sigma),孵育过夜。TBST洗膜5次,每次5分钟。加入1:3000稀释的辣根过氧化酶标记的兔二抗(JacksonImmunoResearch),孵育1.5小时。TBST(150mM NaCl,20mM Tris-HCl,pH7.4,Tween-20 0.05%)洗膜三次后加入超敏ECL化学发光试剂(碧云天公司),放入暗盒中曝光。The protein samples on the gel were transferred to PVDF membrane, blocked with 5% skimmed milk powder for 1 hour, then added 1:1000 diluted anti-Guf1 antibody (sigma) and incubated overnight. Wash the membrane 5 times with TBST, 5 minutes each time. Horseradish peroxidase-labeled rabbit secondary antibody (JacksonImmunoResearch) diluted 1:3000 was added and incubated for 1.5 hours. After washing the membrane three times with TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%), add ultra-sensitive ECL chemiluminescence reagent (Beiyuntian Company), and put it into a cassette for exposure.
实施例2、Guf1基因敲除引起的雄性不育病理学分析。Example 2. Pathological analysis of male sterility caused by Guf1 gene knockout.
为了进一步研究Guf1的缺失会引起那些功能障碍,我们着重对Guf1基因敲除小鼠的生殖进行病理学研究,包括后代数目,精子运动能力,以及睾丸的病理切片和透射电镜分析。图2A代表后代数目分析,表明雄性敲除型小鼠和正常雌鼠合笼后,有交配行为但不产生后代。图2B统计野生型和Guf1敲除小鼠的精子数目,表明Guf1敲除小鼠精子数目显著减少。图2C是睾丸形态观察,发现Guf1敲除小鼠的睾丸形态变小。图2D是共聚焦荧光显微镜观察精子形态,发现敲除型精子线粒体鞘有缺失,弯折现象,线粒体异常。In order to further study the dysfunction caused by the loss of Guf1, we focused on the pathological study of the reproduction of Guf1 knockout mice, including the number of offspring, sperm motility, and pathological sections and transmission electron microscope analysis of testes. Figure 2A represents the analysis of the number of offspring, which shows that after male knockout mice and normal female mice were caged, there was mating behavior but no offspring were produced. Figure 2B counts the sperm counts of wild-type and Guf1-knockout mice, showing that the number of sperm in Guf1-knockout mice is significantly reduced. Figure 2C is the observation of testis morphology, and it was found that the testis morphology of Guf1 knockout mice became smaller. Figure 2D shows the morphology of sperm observed under a confocal fluorescence microscope. It was found that the mitochondrial sheath of the knockout sperm was missing, bent, and abnormal mitochondria.
具体方法:specific method:
雄性生殖能力分析:分别取6-8周龄的20只野生型和Guf1敲除型小鼠,每只小鼠与两只6-7周龄的CD1雌鼠合笼,每天早晨验栓,将有阴栓的小鼠取出单独饲养,统计其后代数目,结果发现与野生型小鼠交配的40只雌鼠,都见栓,只有两只没有后代,其余生出4-12只幼鼠。而与敲除型小鼠交配的40只CD1雌鼠,见栓但没有后代。Analysis of male reproductive ability: 20 wild-type and Guf1 knockout mice aged 6-8 weeks were taken respectively, and each mouse was co-caged with two CD1 female mice aged 6-7 weeks. The mice with vaginal plugs were taken out and raised separately, and the number of offspring was counted. It was found that 40 female mice mated with wild-type mice all had plugs, only two had no offspring, and the rest gave birth to 4-12 pups. In contrast, 40 CD1 female mice mated with knockout mice had no offspring.
精子数目统计:取6-8周龄野生和敲除型小鼠(n>3),断颈处死,用剪刀取出附睾,放入装有磷酸盐缓冲液(PBS)的平皿中,用注射器将附睾扎碎,血球计数板计数。Sperm count statistics: 6-8 weeks old wild and knockout mice (n>3) were killed by neck dislocation, the epididymis was taken out with scissors, put into a plate filled with phosphate buffered saline (PBS), and injected with a syringe. The epididymis was shattered and counted on a blood cell count.
共聚焦荧光显微镜观察精子形态:取6-8周龄野生和敲除型小鼠(n>3),断颈处死,用剪刀取出附睾,注射器将附睾扎碎,Hoechest和Mitotracker(invitrogen)用PBS 1:10000稀释,共聚焦荧光显微镜观察精子。Observation of sperm morphology by confocal fluorescence microscope: 6-8 weeks old wild and knockout mice (n>3) were killed by neck dislocation, the epididymis was taken out with scissors, the epididymis was crushed with a syringe, Hoechest and Mitotracker (invitrogen) were washed with PBS 1:10000 dilution, spermatozoa were observed by confocal fluorescence microscope.
实施例3、Guf1敲除增加精细胞凋亡,影响精子发生过程。Example 3. Guf1 knockout increases sperm cell apoptosis and affects spermatogenesis.
为了研究Guf1对于小鼠精子发生过程的影响,我们对野生型和Guf1敲除雄鼠的生殖器官包括睾丸和附睾进行切片染色,以及精子运动能力分析。图3A、C是敲除型附睾和睾丸的H&E染色,该结果表明敲除型小鼠附睾中存在大量的未成熟精细胞。图3B是TUNEL检测睾丸和附睾中的凋亡现象,表明Guf1敲除后会产生明显的凋亡现象。图3D、E是计算机辅助精子分析(computer assisted sperm analyzer,CASA)对精子运动能力的分析,结果表明敲除小鼠精子运动能力明显降低。通过以上对Guf1敲除的病理学分析,发现Guf1敲除会引起精子发生障碍,导致雄性不育。In order to study the effect of Guf1 on the process of mouse spermatogenesis, we stained the reproductive organs of wild-type and Guf1-knockout male mice, including testes and epididymis, and analyzed sperm motility. Figure 3A, C are the H&E staining of the knockout epididymis and testis, the results show that there are a large number of immature sperm cells in the knockout mouse epididymis. Figure 3B is TUNEL detection of apoptosis in testis and epididymis, indicating that Guf1 knockout will produce obvious apoptosis. Figure 3D and E are the analysis of sperm motility by computer assisted sperm analyzer (CASA), and the results show that the sperm motility of knockout mice is significantly reduced. Through the above pathological analysis of Guf1 knockout, it was found that Guf1 knockout would cause spermatogenesis disorder and lead to male sterility.
具体方法:specific method:
附睾和睾丸的H&E染色:H&E staining of epididymis and testis:
石蜡切片:取下野生型和Guf1基因敲除小鼠睾丸和附睾组织,放入4%的过氟烷基化物(Polyfluoroalkoxy,PFA)中固定,以防止细胞死后的自溶或细菌的分解,从而保持细胞本来的形态结构。Paraffin section: Remove the testis and epididymis tissues of wild-type and Guf1 knockout mice, and fix them in 4% perfluoroalkoxy (Polyfluoroalkoxy, PFA) to prevent autolysis or bacterial decomposition after cell death. In order to maintain the original shape and structure of the cells.
脱水透明:用由低浓度到高浓度的乙醇作脱水剂,逐渐脱去组织中的水分。然后放于透明剂二甲苯中透明。Dehydration and transparency: Use ethanol from low concentration to high concentration as dehydrating agent to gradually remove the water in the tissue. Then put it in transparent agent xylene to make it transparent.
浸蜡包埋:将小盒中倒入已融化的石蜡,组织放于其中,冷却凝固。Wax-immersion embedding: Pour melted paraffin into the small box, put the tissue in it, and let it cool and solidify.
切片与贴片:将包埋好的蜡块放于切片机中,切成薄片,5-8μm,薄片放到42度的热水中展片,贴到载玻片上,放于恒温箱中烘干。Slicing and patching: put the embedded wax block in a microtome, cut into thin slices, 5-8μm, put the thin slices in hot water at 42 degrees to spread the slices, paste them on glass slides, and put them in a constant temperature box for drying Dry.
脱蜡染色:染色前,将烘干的石蜡切片放于二甲苯中脱去石蜡,再经由高浓度到低浓度乙醇,最后加入到蒸馏水。片子放于苏木精水溶液中染色几分钟,流水冲洗1小时后加入蒸馏水片刻,入70%和90%酒精中脱水各10分钟。加入伊红染色液染色2-3分钟。Dewaxing staining: Before staining, put the dried paraffin sections in xylene to deparaffinize, then pass through high-concentration to low-concentration ethanol, and finally add distilled water. The slices were stained in hematoxylin aqueous solution for several minutes, rinsed with running water for 1 hour, added distilled water for a while, and dehydrated in 70% and 90% alcohol for 10 minutes each. Add eosin staining solution and stain for 2-3 minutes.
脱水透明:染色后切片经不同浓度的乙醇脱水,再经二甲苯使切片透明。Dehydration and transparency: After staining, the sections were dehydrated with different concentrations of ethanol, and then xylene was used to make the sections transparent.
封固:将透明好的切片滴上树胶,盖上盖玻片封固。Mounting: Drop the transparent slices with gum and cover with a cover slip for mounting.
TUNEL细胞凋亡检测:TUNEL cell apoptosis detection:
制作睾丸和附睾的石蜡切片,切片用二甲苯浸洗2次,每次5分钟。将透明好的片子放于梯度乙醇(100%,95%,90%,80%,70%)各浸洗1次,每次3分钟。片子PBS洗涤2次。用蛋白酶K工作液处理组织20分钟。之后PBS洗涤2次。制备TUNEL反应混合液,50μl TdT+450μl荧光素标记的dUTP液混匀。片子干后加入50μl TUNEL反应混合液,在暗湿盒中37度反应1小时。PBS漂洗3次。拍照。Paraffin sections of the testis and epididymis were made, and the sections were dipped in xylene twice for 5 minutes each time. The transparent slices were dipped in graded ethanol (100%, 95%, 90%, 80%, 70%) for 3 minutes each time. The slides were washed twice with PBS. Treat tissue with proteinase K working solution for 20 minutes. Then washed twice with PBS. Prepare TUNEL reaction mixture, mix 50μl TdT+450μl fluorescein-labeled dUTP solution. Add 50 μl TUNEL reaction mixture after the slides are dry, and react in a dark and humid box at 37°C for 1 hour. Rinse with PBS 3 times. Photograph.
计算机辅助精子分析(CASA)评价精子各项运动参数:取6-8周龄野生型和敲除型小鼠各4只,将其附睾取出,精子置于37度水浴,计数池放分析仪恒温板上预温,精子标本液化后取混匀样本精液1滴滴在样品池中间,然后进行分析。采用中科计算机辅助精液分析软件(中科院动物所),对精液主要参数即精子活动力、及精子平均曲线运动速度(VCL)、平均直线运动速度(VSL)、平均路径运动速度(VAP)、平均鞭打频率(BCF)等进行分析。Computer-assisted sperm analysis (CASA) to evaluate various sperm movement parameters: take 4 wild-type mice and 4 knock-out mice aged 6-8 weeks, take out the epididymis, put the sperm in a 37-degree water bath, and put the counting pool in the analyzer to maintain a constant temperature Pre-warm on the plate, after the sperm sample is liquefied, take 1 drop of the mixed sample semen and drop it in the middle of the sample pool, and then analyze it. Using computer-aided semen analysis software of Chinese Academy of Sciences (Institute of Zoology, Chinese Academy of Sciences), the main parameters of semen, namely sperm motility, and sperm average curve velocity (VCL), average linear velocity (VSL), average path velocity (VAP), average Whiplash frequency (BCF) etc. were analyzed.
实施例4、Guf1敲除小鼠的睾丸和精子线粒体的透射电镜观察。Example 4. Transmission electron microscope observation of testes and sperm mitochondria of Guf1 knockout mice.
以前研究表明,Guf1是定位于线粒体的蛋白。为了研究Guf1蛋白对线粒体功能的影响,我们对Guf1敲除小鼠的生殖器官的线粒体结构和功能进行研究。图4为Guf1敲除对小鼠睾丸和精子线粒体形态的影响。图4A、C分别代表Guf1蛋白敲除的精原细胞和精母细胞透射电镜,结果表明Guf1敲除小鼠发育到精母细胞线粒体形态发生变化。图4B、D代表Guf1敲除小鼠的精子线粒体鞘,结果显示Guf1缺失会引起精子线粒体形态发生明显改变,体现在精子线粒体鞘线粒体摆列不整齐,内脊有缺损。Previous studies have shown that Guf1 is a mitochondria-localized protein. In order to study the effect of Guf1 protein on mitochondrial function, we studied the mitochondrial structure and function of the reproductive organs of Guf1 knockout mice. Figure 4 shows the effect of Guf1 knockout on the mitochondrial morphology of mouse testis and sperm. Figure 4A and C represent the transmission electron microscope of Guf1 protein-knockout spermatogonia and spermatocytes, respectively, and the results show that the mitochondrial morphology of spermatocytes in Guf1 knockout mice changes during development. Figure 4B and D represent the sperm mitochondrial sheath of Guf1-knockout mice. The results show that the absence of Guf1 can cause significant changes in the morphology of sperm mitochondria, which is reflected in the irregular arrangement of mitochondria in the sperm mitochondrial sheath and defects in the inner ridge.
具体方法:specific method:
睾丸和附睾组织透射电镜:睾丸和附睾从野生和敲除型小鼠活体取下来,放入四氧化锇中固定1-2小时。固定完毕,用缓冲液漂洗20分钟后进行脱水。脱水梯度依次为:30%丙酮,50%丙酮,70%丙酮,80%丙酮,90%丙酮,每级作用30分钟。纯丙酮作用3次,每次30分钟。样品进行渗透后做超薄切片,最后染色,先柠檬酸铅染色10分钟,去二氧化碳的双蒸水清洗3次,再用醋酸铀染色30分钟,双蒸水清洗3次。等超薄切片干燥后,即可上透射电子显微镜Tecnai Spirit(120KV)观察。Transmission electron microscopy of testis and epididymis: testes and epididymis were removed from wild and knockout mice, and fixed in osmium tetroxide for 1-2 hours. After fixation, rinse with buffer for 20 minutes and then dehydrate. The dehydration gradient is as follows: 30% acetone, 50% acetone, 70% acetone, 80% acetone, 90% acetone, each step acts for 30 minutes. Pure acetone was applied 3 times, 30 minutes each time. The samples were infiltrated and made ultra-thin sections, and finally stained, first stained with lead citrate for 10 minutes, washed 3 times with double distilled water to remove carbon dioxide, then stained with uranyl acetate for 30 minutes, washed 3 times with double distilled water. After the ultra-thin sections are dry, they can be observed with a transmission electron microscope Tecnai Spirit (120KV).
实施例5、Guf1蛋白对线粒体呼吸链复合物功能的影响。Example 5. Effect of Guf1 protein on the function of mitochondrial respiratory chain complex.
为了进一步研究Guf1对于线粒体功能的影响,我们对线粒体氧化磷酸化系统进行研究,同时以正常组织心脏作为对照。图3A代表野生型和敲除型睾丸和附睾的ATP水平,结果显示在Guf1敲除的情况下睾丸和附睾ATP水平下降。图3B代表线粒体细胞色素c氧化酶的活性,结果表明Guf1敲除的睾丸和附睾中细胞色素c氧化酶的活性降低。图3C代表Blue native PAGE分析线粒体呼吸链各复合物,结果表明细胞色素c氧化酶的量在敲除型睾丸和附睾中明显减少。图3D代表细胞色素c氧化酶的BNG染色,结果表明细胞色素c氧化酶的活性明显降低。图3E代表线粒复合物I,复合物II和复合物V的活性染色,结果表明复合物I、V、II的活性没有明显变化。In order to further study the effect of Guf1 on mitochondrial function, we studied the mitochondrial oxidative phosphorylation system, while using normal tissue heart as a control. Figure 3A represents the ATP levels of wild-type and knockout testis and epididymis, and the results show that testis and epididymis ATP levels were decreased in the case of Guf1 knockout. Figure 3B represents the activity of mitochondrial cytochrome c oxidase, and the results show that the activity of cytochrome c oxidase is reduced in Guf1 knockout testis and epididymis. Figure 3C represents the Blue native PAGE analysis of the complexes of the mitochondrial respiratory chain, and the results showed that the amount of cytochrome c oxidase was significantly reduced in the knockout testis and epididymis. Figure 3D represents the BNG staining of cytochrome c oxidase, which shows that the activity of cytochrome c oxidase is significantly reduced. Figure 3E represents the activity staining of complex I, complex II and complex V in mitochondria, and the results showed that the activity of complex I, V, II did not change significantly.
具体方法:specific method:
ATP水平测定:取6-8周龄野生型和敲除型小鼠的睾丸、附睾,PBS洗三次。睾丸去白膜,灭菌刀片将睾丸,附睾切碎,0.25%的胰酶消化,每次5分钟,共15分钟。得到单细胞,细胞裂解后,13000rpm离心10分钟,上清用BCA试剂盒测定蛋白浓度。取5μl样品加入50μl ATP检测buffer,化学发光酶标仪(Perkin Elmer,USA)检测仪检测。Determination of ATP level: the testes and epididymis of 6-8 week old wild-type and knockout mice were washed three times with PBS. Remove the tunica from the testis, chop the testis and epididymis with a sterilized blade, and digest with 0.25% trypsin, 5 minutes each time, 15 minutes in total. Single cells were obtained. After the cells were lysed, they were centrifuged at 13,000 rpm for 10 minutes, and the protein concentration of the supernatant was determined with a BCA kit. Take 5 μl of sample and add 50 μl of ATP detection buffer, and detect with a chemiluminescent microplate reader (Perkin Elmer, USA) detector.
Blue Native PAGE:按照线粒体分离试剂盒(Abcam)分离小鼠心脏和睾丸线粒体,BCA试剂盒测定蛋白浓度。取400μg线粒体12000rpm离心5分钟,加入40μl缓冲液A(50mM氯化钠,50mM咪唑/盐酸,1mMEDTA,pH 7.0)重悬。每管加入12μl Digitonin,混匀冰上作用10分钟。100000g,4度离心30分钟,取上清,加入5μl甘油和6μl考马斯亮蓝。取20μl样品进行Blue-native PAGE分离线粒体复合物,方法见参考文献(Ilka Wittig等,nature 2006)。Blue Native PAGE: According to the Mitochondria Isolation Kit (Abcam), mouse heart and testicular mitochondria were separated, and the BCA kit was used to determine the protein concentration. Centrifuge 400 μg mitochondria at 12000 rpm for 5 minutes, add 40 μl buffer A (50 mM sodium chloride, 50 mM imidazole/hydrochloric acid, 1 mM EDTA, pH 7.0) to resuspend. Add 12μl Digitonin to each tube, mix well and act on ice for 10 minutes. Centrifuge at 100,000g at 4°C for 30 minutes, take the supernatant, add 5 μl glycerol and 6 μl Coomassie brilliant blue. Take 20 μl samples for Blue-native PAGE to separate mitochondrial complexes, see the reference (Ilka Wittig et al., nature 2006) for the method.
复合物I活性:将Blue-native PAGE分离胶孵育在50mM Tris-Hcl,pH 7.4缓冲液中(含有0.5mM NBT(Nitroblue tetrazolium chloride,氯化硝基四氮唑),5mM NADH(Nicotinamide adenine dinucleotide,烟酰胺腺嘌呤二核苷酸)),室温作用1小时。Complex I activity: Incubate the Blue-native PAGE separation gel in 50mM Tris-Hcl, pH 7.4 buffer (containing 0.5mM NBT (Nitroblue tetrazolium chloride, nitrotetrazolium chloride), 5mM NADH (Nicotinamide adenine dinucleotide, Nicotinamide adenine dinucleotide)) at room temperature for 1 hour.
复合物II活性:将Blue-native PAGE分离胶孵育在50mM Tris-Hcl,pH 7.4缓冲液中(0.2mM PMS(Methylphenaziniummethylsulfate,吩嗪甲基硫酸盐),84mM琥珀酸,50mM NBT),室温作用1小时。Complex II activity: Incubate the Blue-native PAGE separation gel in 50mM Tris-Hcl, pH 7.4 buffer (0.2mM PMS (Methylphenaziniummethylsulfate, phenazine methylsulfate), 84mM succinic acid, 50mM NBT), room temperature for 1 Hour.
复合物IV活性:将Blue-native PAGE分离胶孵育在50mM Tris-Hcl,pH 7.4缓冲液中(含有0.1%二氨基联苯胺,24个单位/ml过氧化氢酶,0.1%细胞色素c),37度作用3-6小时。Complex IV activity: incubate Blue-native PAGE gel in 50mM Tris-Hcl, pH 7.4 buffer (containing 0.1% diaminobenzidine, 24 units/ml catalase, 0.1% cytochrome c), 37 degrees for 3-6 hours.
复合物V活性:将Blue-native PAGE分离胶用清水漂洗10分钟,放入0.1M的甘氨酸缓冲液中(pH 8.6)作用1小时。再将分离胶放入含有下列成分的缓冲液中:35mM Tris碱,270mM甘氨酸,14mM硫酸镁,5mMATP,0.2%硝酸银,37度作用3-6小时。Complex V activity: Rinse the Blue-native PAGE separation gel with water for 10 minutes, and put it into 0.1M glycine buffer (pH 8.6) for 1 hour. Then put the separating gel into the buffer containing the following components: 35mM Tris base, 270mM glycine, 14mM magnesium sulfate, 5mMATP, 0.2% silver nitrate, and act for 3-6 hours at 37 degrees.
实施例6、Guf1敲除对线粒体呼吸链复合物亚基蛋白的影响。Example 6. Effect of Guf1 knockout on mitochondrial respiratory chain complex subunit proteins.
以上研究表明Guf1敲除会引起小鼠睾丸和附睾的电子传递链细胞色素c氧化酶活性明显下降,所以我们对线粒体电子传递链各复合物亚基的量进行研究,同时以正常组织心脏作为对照。图A表示心脏和睾丸以及附睾中复合物I-V各亚蛋白的western blot结果,结果显示敲除型小鼠的睾丸和附睾中复合物IV中Cox IV(核基因编码),Cox1、Cox2(线粒体基因组编码)的量显著减少。复合物I中ND2量降低,而NDUFA9量没有任何变化。复合物III中细胞色素b(CYTB)的量在敲除型睾丸中减少,而核编码的Core2量不变。复合物II中70kd Fp的量没有变化。复合物V中ATP5A量也没有变化。图B是Blue native western blot的结果进一步表明线粒体复合物IV的量减少。图C是Blue-native 2D结果说明复合物IV各亚蛋白的量比起其它复合物各亚蛋白量减少得更为显著。The above studies have shown that Guf1 knockout can cause a significant decrease in the activity of cytochrome c oxidase in the electron transport chain of the mouse testis and epididymis, so we studied the amount of each complex subunit of the mitochondrial electron transport chain, and at the same time, the normal tissue heart was used as a control . Panel A shows the western blot results of each subprotein of complex I-V in the heart, testis and epididymis, and the results show that Cox IV (encoded by nuclear genes), Cox1 and Cox2 (encoded by mitochondrial genome) in complex IV in testis and epididymis of knockout mice coding) is significantly reduced. The amount of ND2 was reduced in complex I without any change in the amount of NDUFA9. The amount of cytochrome b (CYTB) in complex III was reduced in knockout testes, whereas the amount of nuclear-encoded Core2 was unchanged. The amount of 70kd Fp in complex II was unchanged. There was also no change in the amount of ATP5A in complex V. Panel B is the result of Blue native western blot, which further shows that the amount of mitochondrial complex IV is reduced. Figure C is the result of Blue-native 2D, which shows that the amount of each subprotein of complex IV is more significantly reduced than that of other complexes.
具体方法:specific method:
蛋白免疫印迹(western blot):取6-8周龄的野生型和Guf1敲除型小鼠断颈处死,取出小鼠心脏,睾丸和附睾组织,PBS漂洗。加入RIPA裂解液1ml,同时加入蛋白酶抑制剂cocktail(Roche),放入组织研磨器中研磨,匀浆液冰上放置30分钟,12000rpm离心30分钟,上清用BCA试剂盒测定蛋白浓度。Western blot: 6-8 week old wild-type and Guf1 knockout mice were killed by neck dislocation, and the mouse heart, testis and epididymis tissues were taken out and washed with PBS. Add 1ml of RIPA lysate and protease inhibitor cocktail (Roche) at the same time, grind in a tissue grinder, place the homogenate on ice for 30 minutes, centrifuge at 12000rpm for 30 minutes, and use the BCA kit to measure the protein concentration of the supernatant.
配制15% SDS-PAGE胶,将已经测好蛋白浓度的样品,加上一定体积的蛋白上样缓冲液,95度加热15分钟,取一定量蛋白加入到15%SDS-PAGE胶中,100v恒压,电泳3小时左右。Prepare 15% SDS-PAGE gel, add a certain volume of protein loading buffer to the sample whose protein concentration has been measured, heat at 95 degrees for 15 minutes, take a certain amount of protein and add it to 15% SDS-PAGE gel, 100v constant Pressure, electrophoresis about 3 hours.
将胶上的蛋白样品转移到PVDF膜上,5%脱脂奶粉封闭1小时,然后不同一抗(Abcam)按照说明书稀释,孵育过夜。TBST(150mM NaCl,20mM Tris-HCl,pH7.4,Tween-20 0.05%)洗膜5次,每次5分钟。二抗1:3000稀释,孵育1.5小时。TBST洗膜三次后加入超敏ECL化学发光试剂(碧云天公司),放入暗盒中曝光。The protein samples on the gel were transferred to PVDF membrane, blocked with 5% skimmed milk powder for 1 hour, and then diluted with different primary antibodies (Abcam) according to the instructions, and incubated overnight. Wash the membrane 5 times with TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%), 5 minutes each time. The secondary antibody was diluted 1:3000 and incubated for 1.5 hours. After washing the membrane three times with TBST, an ultra-sensitive ECL chemiluminescent reagent (Biyuntian Company) was added and placed in a cassette for exposure.
Blue-native 2D:首先按照以上的实验方法进行Blue native PAGE电泳,然后将胶置于固定液中固定1小时,考马斯亮蓝染色2小时以上。将胶切下,放于1%巯基乙醇(痕量溴酚蓝)放置1小时。配制10%Tricine-SDS-PAGE,将胶置于Tricine-SDS-PAGE的积层胶中,恒流20mA,电泳完毕后考马斯亮蓝染色,脱色。Blue-native 2D: First, perform Blue native PAGE electrophoresis according to the above experimental method, then fix the gel in fixative solution for 1 hour, and stain with Coomassie brilliant blue for more than 2 hours. The gel was excised and placed in 1% mercaptoethanol (trace bromophenol blue) for 1 hour. Prepare 10% Tricine-SDS-PAGE, put the gel in the stacking gel of Tricine-SDS-PAGE, constant current 20mA, after electrophoresis, Coomassie brilliant blue staining and decolorization.
实施例7、Guf1敲除引起胞质翻译降低和mTOR信号通路降低。Example 7. Guf1 knockout causes decreased cytoplasmic translation and mTOR signaling pathway.
为了在真核细胞中研究Guf1基因的功能,我们研究Guf1引起的信号通路变化和胞质翻译水平以此揭示Guf1在生物体内的意义。图4A为睾丸的磷酸化芯片结果,结果显示Guf1主要与癌症相关,同时mTOR信号通路相关蛋白表达降低。图4B为western blot验证mTOR信号通路相关蛋白的表达情况,结果表明mTOR下游的底物4E-BP的Thr37/46磷酸化水平下降,与芯片结果一致。图4C为胞质核糖体展示技术观察胞质翻译水平,结果发现敲除型小鼠胞质翻译降低。In order to study the function of Guf1 gene in eukaryotic cells, we studied the changes of signaling pathway and cytoplasmic translation level caused by Guf1 to reveal the significance of Guf1 in vivo. Figure 4A is the result of the phosphorylation microarray of the testis, the results show that Guf1 is mainly related to cancer, and the expression of proteins related to the mTOR signaling pathway is reduced. Figure 4B shows the expression of mTOR signaling pathway-related proteins verified by western blot. The results show that the phosphorylation level of Thr37/46 of the substrate 4E-BP downstream of mTOR decreases, which is consistent with the chip results. Figure 4C shows the observation of cytoplasmic translation level by cytoplasmic ribosome display technology, and it was found that the cytoplasmic translation of knockout mice was reduced.
具体方法:specific method:
蛋白免疫印迹(western blot):取6-8周龄野生型和Guf1敲除型小鼠断颈处死,取出小鼠心脏和睾丸组织,PBS漂洗。加入RIPA裂解液1ml,加入蛋白酶抑制剂cocktail(Roche)和磷酸酶抑制剂(Roche),放入组织研磨器研磨,匀浆液冰上放置30分钟,12000rpm离心30分钟,上清用BCA试剂盒测定蛋白浓度。Western blot: 6-8 week-old wild-type and Guf1 knockout mice were killed by neck dislocation, and the heart and testis tissues of the mice were taken out and rinsed with PBS. Add 1ml of RIPA lysate, add protease inhibitor cocktail (Roche) and phosphatase inhibitor (Roche), put it into a tissue grinder for grinding, place the homogenate on ice for 30 minutes, centrifuge at 12000rpm for 30 minutes, and measure the supernatant with a BCA kit protein concentration.
配制15%SDS-PAGE胶,将已经测好蛋白浓度的样品,加上一定体积的蛋白上样缓冲液,95度加热15分钟,取一定量蛋白加入到15%SDS-PAGE胶中,100v恒压,电泳3小时左右。Prepare 15% SDS-PAGE gel, add a certain volume of protein loading buffer to the sample whose protein concentration has been measured, heat at 95 degrees for 15 minutes, take a certain amount of protein and add it to 15% SDS-PAGE gel, 100v constant Pressure, electrophoresis about 3 hours.
将胶上的蛋白样品转移到PVDF膜上,5%脱脂奶粉封闭1小时,然后不同一抗(Cell signal technology)按照说明书稀释,孵育过夜。TBST(150mM NaCl,20mM Tris-HCl,pH7.4,Tween-20 0.05%)洗膜5次后,二抗(辣根过氧化物酶标记)1:3000稀释,孵育1.5小时。TBST洗膜5次后加入超敏ECL化学发光试剂(碧云天公司),放入暗盒中曝光。The protein samples on the gel were transferred to PVDF membrane, blocked with 5% skimmed milk powder for 1 hour, and then different primary antibodies (Cell signal technology) were diluted according to the instructions and incubated overnight. After washing the membrane 5 times with TBST (150mM NaCl, 20mM Tris-HCl, pH7.4, Tween-20 0.05%), the secondary antibody (labeled with horseradish peroxidase) was diluted 1:3000 and incubated for 1.5 hours. After washing the membrane 5 times with TBST, the supersensitive ECL chemiluminescent reagent (Biyuntian Company) was added, and the membrane was placed in a cassette for exposure.
胞质核糖体展示技术:Cytoplasmic ribosome display technology:
配制TMK裂解缓冲液:To prepare TMK Lysis Buffer:
10mM Tris-Cl,pH 7.4:1ml的1M Tris-Cl10mM Tris-Cl, pH 7.4: 1ml of 1M Tris-Cl
10mM氯化镁:0.5ml的1M氯化镁10mM MgCl: 0.5ml of 1M MgCl
100mM氯化钾:10ml的1M氯化钾100mM KCl: 10ml of 1M KCl
1%(v/v)Triton X-100:1ml1% (v/v) Triton X-100: 1ml
0.5%(w/v)脱氧胆酸钠:0.5g0.5% (w/v) sodium deoxycholate: 0.5g
1U/ml RNA酶抑制剂:2.5μl 40U/μl1U/ml RNase inhibitor: 2.5μl 40U/μl
2mM DTT:200μl的1M DTT2mM DTT: 200 μl of 1M DTT
放线菌酮:0.1mg/mlCycloheximide: 0.1mg/ml
加入DEPC-H2O至100ml。Add DEPC- H2O to 100ml.
配制10%-50%蔗糖:在4度用DEPC水配制。Prepare 10%-50% sucrose: prepare with DEPC water at 4 degrees.
10%(w/v)蔗糖溶液的配制(200ml):Preparation of 10% (w/v) sucrose solution (200ml):
蔗糖:20gSucrose: 20g
100mM氯化钾:20ml的1M氯化钾100mM KCl: 20ml of 1M KCl
5mM氯化镁:1ml的氯化镁5mM MgCl: 1ml MgCl
2mM DTT:400μl的1M DTT2mM DTT: 400 μl of 1M DTT
20mM HEPES,pH 7.4:4ml的1M HEPES20mM HEPES, pH 7.4: 4ml of 1M HEPES
50%(w/v)蔗糖溶液的配制(200ml):Preparation of 50% (w/v) sucrose solution (200ml):
蔗糖:100gSucrose: 100g
100mM氯化钾:20ml的1M氯化钾100mM KCl: 20ml of 1M KCl
5mM氯化镁:1ml of氯化镁5mM magnesium chloride: 1ml of magnesium chloride
2mM DTT:400μl的1M DTT2mM DTT: 400 μl of 1M DTT
20mM HEPES,pH 7.4:4ml的1M HEPES20mM HEPES, pH 7.4: 4ml of 1M HEPES
在用之前加入2μl(40U/μl)RNA酶抑制剂和50μl放线菌酮(100μg/μl)于50ml蔗糖中。放于梯度混合仪配制梯度。Add 2 μl (40 U/μl) RNase inhibitor and 50 μl cycloheximide (100 μg/μl) in 50 ml sucrose just before use. Put it in the gradient mixer to prepare the gradient.
野生型和Guf1敲除型小鼠断颈处死,立即取出心脏和睾丸放于液氮中速冻,无RNA酶的研钵研磨成粉末,倒入到EP管中,加入TMK裂解液,冰上裂解5分钟。13000g离心20分钟。上清铺于10%-50%的蔗糖梯度中。26000rpm离心4小时。核酸检测仪A260检测。Wild-type and Guf1-knockout mice were killed by neck dislocation, and the heart and testis were immediately taken out and frozen in liquid nitrogen, ground into powder in a mortar without RNase, poured into EP tubes, added TMK lysate, and lysed on ice 5 minutes. Centrifuge at 13000g for 20 minutes. The supernatant was plated in a 10%-50% sucrose gradient. Centrifuge at 26000 rpm for 4 hours. Nucleic acid detector A260 detection.
实施例8、Guf1蛋白敲除对线粒体拷贝,转录和翻译的影响。Example 8. Effect of Guf1 protein knockout on mitochondrial copy, transcription and translation.
在酵母中的研究表明,Guf1是重要的线粒体蛋白质翻译因子。为了进一步研究Guf1在真核细胞中对线粒体蛋白质合成的影响。我们做了如下研究,图A是测定野生型和Guf1敲除型小鼠的心脏、睾丸以及附睾中线粒体DNA的拷贝数,结果表明线粒体DNA的拷贝数有所增加。图C,E是表示线粒体各复合物蛋白的mRNA水平,其中C是睾丸的结果,E图是心脏结果,结果表明线粒体各复合物蛋白的mRNA水平在野生型和敲除型心脏和睾丸中没有明显变化,Guf1敲除不影响线粒体DNA的转录。图B是线粒体核糖体大亚基L11和核糖体小亚基S18的量变化,结果显示敲除型睾丸中L11和S18的量稍有增加。图D是线粒体蛋白质体外翻译,结果表明在Guf1敲除的睾丸中,线粒体蛋白质体外翻译的量增加。Studies in yeast have shown that Guf1 is an important mitochondrial protein translation factor. To further study the effect of Guf1 on mitochondrial protein synthesis in eukaryotic cells. We did the following research. Figure A is to measure the copy number of mitochondrial DNA in the heart, testis and epididymis of wild-type and Guf1 knockout mice, and the results show that the copy number of mitochondrial DNA has increased. Figures C and E represent the mRNA levels of mitochondrial complex proteins, where C is the result of testis, and Figure E is the result of heart. The results show that the mRNA levels of mitochondrial complex proteins have no difference in wild-type and knockout heart and testis Clearly, Guf1 knockdown did not affect mitochondrial DNA transcription. Panel B shows the changes in the amount of the large mitochondrial ribosomal subunit L11 and the small ribosomal subunit S18, and the results show that the amounts of L11 and S18 in the knockout testis were slightly increased. Panel D is the in vitro translation of mitochondrial proteins, and the results show that in Guf1 knockout testes, the amount of mitochondrial protein translation in vitro increases.
具体方法:specific method:
线粒体DNA拷贝数的测定:Determination of mitochondrial DNA copy number:
提取野生型和Guf1敲除型小鼠的心脏和睾丸的DNA,合成线粒体DNA(mtDNA)编码的cox1基因引物和细胞核DNA(nDNA)编码的ndufv1基因的引物。以心脏和睾丸的基因组DNA为模板,qPCR扩增cox1和ndufv基因。cox1和ndufv的比值代表mtDNA/nDNA。The heart and testis DNA of wild-type and Guf1 knockout mice were extracted, and the primers of cox1 gene encoded by mitochondrial DNA (mtDNA) and ndufv1 gene encoded by nuclear DNA (nDNA) were synthesized. The cox1 and ndufv genes were amplified by qPCR using genomic DNA from the heart and testis as templates. The ratio of cox1 and ndufv represents mtDNA/nDNA.
线粒体各复合物蛋白qPCR:Trizol试剂提取野生型和Guf1敲除型小鼠心脏和睾丸的总RNA,以2μg总RNA为模板,用莫洛尼小鼠白血病病毒逆转录酶(Molony murine leukemia virus reverse transcriptase,MoMuLVRT)为模板,以多聚胸腺嘧啶(oligo(dT))为引物合成cDNA.参照文献合成16S rRNA,12S rRNA,ND1,ND6,NDUFS3,NDUFS7,NDUFB6,NDUFA9(NADH脱氢酶亚基),Cox1,Cox2(细胞色素氧化酶亚基),CytB(细胞色素还原酶亚基,细胞色素b),ATP6(ATP合成酶亚基),EF-Tu(延伸因子TU)引物。用SYBR Green Master Mix(Takara,Japan)试剂在ABIStepOne plus定量PCR仪进行RT-PCR反应。Mitochondrial complex protein qPCR: Trizol reagent was used to extract the total RNA of heart and testis of wild-type and Guf1 knockout mice, using 2 μg of total RNA as template, using Molony murine leukemia virus reverse transcriptase (Molony murine leukemia virus reverse transcriptase, MoMuLVRT) as a template and polythymine (oligo(dT)) as a primer to synthesize cDNA. Refer to the literature to synthesize 16S rRNA, 12S rRNA, ND1, ND6, NDUFS3, NDUFS7, NDUFB6, NDUFA9 (NADH dehydrogenase subunit ), Cox1, Cox2 (cytochrome oxidase subunit), CytB (cytochrome reductase subunit, cytochrome b), ATP6 (ATP synthase subunit), EF-Tu (elongation factor TU) primers. RT-PCR reaction was carried out in ABIStepOne plus quantitative PCR instrument with SYBR Green Master Mix (Takara, Japan) reagent.
线粒体蛋白质体外翻译:用线粒体分离试剂盒(Abcam)提取野生型和Guf1敲除型小鼠的心脏和睾丸线粒体,BCA试剂盒测定线粒体蛋白浓度。100μg线粒体12000g离心,沉淀用反应缓冲液37度反应1小时。反应缓冲液成分如下:25mM蔗糖,75mM山梨醇,1mM氯化镁,0.05mMEDTA,10mM Tris-HCl,10mM磷酸氢二钾,10mM谷氨酸盐,2.5mM苹果酸,1mM ADP,1mg/ml脱脂牛血清白蛋白,100μg/ml吐根素,100μg/ml放线菌酮,0.2mM氨基酸混合物,1个单位的RNA酶抑制剂。Mitochondrial protein translation in vitro: mitochondrial isolation kit (Abcam) was used to extract heart and testicular mitochondria of wild-type and Guf1 knockout mice, and BCA kit was used to measure mitochondrial protein concentration. 100μg mitochondria were centrifuged at 12000g, and the pellet was reacted with reaction buffer at 37°C for 1 hour. The reaction buffer composition is as follows: 25mM sucrose, 75mM sorbitol, 1mM magnesium chloride, 0.05mM EDTA, 10mM Tris-HCl, 10mM dipotassium hydrogen phosphate, 10mM glutamate, 2.5mM malic acid, 1mM ADP, 1mg/ml defatted bovine serum Albumin, 100 μg/ml ipeacin, 100 μg/ml cycloheximide, 0.2 mM amino acid mixture, 1 unit of RNase inhibitor.
反应完成后,样品12000g离心5分钟,用冷缓冲液(320mM蔗糖;1mM EDTA;10mM Tris-HCl,pH7.4)洗涤3次,沉淀加入1x蛋白上样缓冲液25μl,95度加热10分钟,进行15%-20% SDS-PAGE电泳。制干胶,压磷屏。After the reaction was completed, the sample was centrifuged at 12000g for 5 minutes, washed 3 times with cold buffer (320mM sucrose; 1mM EDTA; 10mM Tris-HCl, pH7.4), and 25μl of 1x protein loading buffer was added to the precipitate, and heated at 95°C for 10 minutes. Perform 15%-20% SDS-PAGE electrophoresis. Make dry glue, press phosphor screen.
实施例9、人精子的保存及其基因组DNA的提取Example 9, Preservation of Human Sperm and Extraction of Genomic DNA
取400微升不育病人的精子(天津市总医院)提取基因组,然后进行测序,图9A表示提取的编号为1、2、3的病人基因组,结果显示提取成功。将上述DNA进行测序,图9B表示测序结果,结果显示在生殖异常的人guf1基因的5’未翻译端有两个碱基(TC)的缺失。我们采用的这个实验方案可以成功的得到精子外显子DNA序列,通过比对分析突变的位点,因此可以成为一个制作试剂盒的基础。Take 400 microliters of sperm from infertile patients (Tianjin General Hospital) to extract the genome, and then perform sequencing. Figure 9A shows the extracted patient genomes numbered 1, 2, and 3, and the results show that the extraction was successful. The above DNA was sequenced, and FIG. 9B shows the sequencing results, and the results showed that there was a deletion of two bases (TC) at the 5' untranslated end of the human guf1 gene with reproductive abnormalities. The experimental program we adopted can successfully obtain the DNA sequence of the sperm exon, and analyze the mutation site by comparison, so it can become a basis for making a kit.
具体方法:specific method:
取样:室温水溶液化(或37℃水浴液化)Sampling: Aqueous solution at room temperature (or liquefaction in a water bath at 37°C)
冻存:Freeze:
将液化的精子与冻存液按1:1混合逐滴慢慢加入,边加入边混匀;4℃冷冻30分钟,液氮15分钟冻存。Mix the liquefied sperm and cryopreservation solution at a ratio of 1:1 and add slowly drop by drop, mixing evenly while adding; freeze at 4°C for 30 minutes, and store in liquid nitrogen for 15 minutes.
精子DNA提取:Sperm DNA Extraction:
1.取200μl精子+200μl Buffer X2于1.5ml离心管,55℃水浴至少1小时(1.5小时),每隔10分钟颠倒混匀;1. Take 200μl sperm + 200μl Buffer X2 in a 1.5ml centrifuge tube, put it in a 55°C water bath for at least 1 hour (1.5 hours), and mix it upside down every 10 minutes;
2.加入400μl的Buffer AL(QIAGEN DNA提取试剂盒中成分)(可能会产生沉淀,70℃能溶解)漩涡振荡15秒,70℃孵育10分钟,简单离心,将盖子上的水滴离下来;2. Add 400 μl of Buffer AL (a component of the QIAGEN DNA extraction kit) (precipitation may occur, it can be dissolved at 70°C) and vortex for 15 seconds, incubate at 70°C for 10 minutes, centrifuge briefly, and remove the water droplets from the lid;
3.加入400μl的乙醇(95%-100%),涡旋振荡混匀15秒,简单离干盖子上的水滴(可能会产生沉淀,沉淀对结果无影响);3. Add 400 μl of ethanol (95%-100%), vortex and mix for 15 seconds, and simply dry the water droplets on the lid (precipitation may occur, which has no effect on the results);
4.将第3步混合物加入反应柱中,8000rpm离心1分钟,换柱于一新的2ml收集管中(若离不干净,再次离心);4. Add the mixture in step 3 to the reaction column, centrifuge at 8000rpm for 1 minute, and replace the column in a new 2ml collection tube (if it is not clean, centrifuge again);
5.加入500μl AW1(QIAGEN DNA提取试剂盒中成分),8000rpm离心1分钟,换柱于一新的收集管中;5. Add 500μl AW1 (the component in the QIAGEN DNA extraction kit), centrifuge at 8000rpm for 1 minute, and replace the column in a new collection tube;
6.加入500μl AW2(QIAGEN DNA提取试剂盒中成分),14000rpm离心3分钟;6. Add 500μl AW2 (component in QIAGEN DNA extraction kit), centrifuge at 14000rpm for 3 minutes;
7.换新收集管,14000rpm空柱离心1分钟;7. Replace the collection tube with a new one, and centrifuge the empty column at 14000rpm for 1 minute;
8.换一新的1.5ml离心管,加入100μl Buffer AE(QIAGEN DNA提取试剂盒中成分)或蒸馏水,室温放置1分钟,8000rpm,离心1分钟(此处AE应分多次加入,确保柱子上DNA的洗脱充分)。8. Change to a new 1.5ml centrifuge tube, add 100μl Buffer AE (a component in the QIAGEN DNA extraction kit) or distilled water, place at room temperature for 1 minute, 8000rpm, and centrifuge for 1 minute (here, AE should be added in several times to ensure that the column sufficient DNA elution).
表1:人guf1基因外显子测序的引物表Table 1: Primer list for exon sequencing of human guf1 gene
参考文献:references:
1.Acin-Perez,R.,Fernandez-Silva,P.,Peleato,M.L.,Perez-Martos,A.,and Enriquez,J.A.(2008).Respiratory active mitochondrial supercomplexes.Mol Cell 32,529-539.1. Acin-Perez, R., Fernandez-Silva, P., Peleato, M.L., Perez-Martos, A., and Enriquez, J.A. (2008). Respiratory active mitochondrial supercomplexes. Mol Cell 32, 529-539.
2.Ashley,T.,Gaeth,A.P.,Creemers,L.B.,Hack,A.M.,and de Rooij,D.G.(2004).Correlation of meiotic events in testis sections and microspreads of mouse spermatocytesrelative to the mid-pachytene checkpoint.Chromosoma 113,126-136.2. Ashley, T., Gaeth, A.P., Creemers, L.B., Hack, A.M., and de Rooij, D.G. (2004). Correlation of meiotic events in testis sections and microspreads of mouse spermatocytes relative to the mid-pachytene checkpoint. 1 Chromos 3 126-136.
3.Azia,A.,Unger,R.,and Horovitz,A.(2012).What distinguishes GroEL substratesfrom other Escherichia coli proteins?The FEBS journal 279,543-550.3. Azia, A., Unger, R., and Horovitz, A. (2012). What distinguishes GroEL substrates from other Escherichia coli proteins? The FEBS journal 279, 543-550.
4.Barrientos,A.,Barros,M.H.,Valnot,I.,Rotig,A.,Rustin,P.,and Tzagoloff,A.(2002).Cytochrome oxidase in health and disease.Gene 286,53-63.4. Barrientos, A., Barros, M.H., Valnot, I., Rotig, A., Rustin, P., and Tzagoloff, A. (2002). Cytochrome oxidase in health and disease. Gene 286, 53-63.
5.Bauerschmitt,H.,Funes,S.,and Herrmann,J.M.(2008).The membrane-boundGTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.TheJournal of biological chemistry 283,17139-17146.5. Bauerschmitt, H., Funes, S., and Herrmann, J.M. (2008). The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions. The Journal of biological chemistry 283, 17139-17146.
6.Bruno,C.,Martinuzzi,A.,Tang,Y.,Andreu,A.L.,Pallotti,F.,Bonilla,E.,Shanske,S.,Fu,J.,Sue,C.M.,Angelini,C.,et al.(1999).A stop-codon mutationin the human mtDNA cytochrome c oxidase I gene disrupts the functional structure ofcomplex IV.American journal of human genetics 65,611-620.6. Bruno, C., Martinuzzi, A., Tang, Y., Andreu, A.L., Pallotti, F., Bonilla, E., Shanske, S., Fu, J., Sue, C.M., Angelini, C., et al. (1999). A stop-codon mutation in the human mtDNA cytochrome oxidase I gene disrupts the functional structure of complex IV. American journal of human genetics 65, 611-620.
7.Caldas,T.,Laalami,S.,and Richarme,G.(2000).Chaperone properties of bacterialelongation factor EF-G and initiation factor IF2.The Journal of biological chemistry 275,855-860.7. Caldas, T., Laalami, S., and Richarme, G. (2000). Chaperone properties of bacterial elongation factor EF-G and initiation factor IF2. The Journal of biological chemistry 275, 855-860.
8.Collins,T.J.,Berridge,M.J.,Lipp,P.,and Bootman,M.D.(2002).Mitochondriaare morphologically and functionally heterogeneous within cells.The EMBO journal 21,1616-1627.8. Collins, T.J., Berridge, M.J., Lipp, P., and Bootman, M.D. (2002). Mitochondria are morphologically and functionally heterogeneous within cells. The EMBO journal 21, 1616-1627.
9.De Martino,C.,Floridi,A.,Marcante,M.L.,Malorni,W.,Scorza Barcellona,P.,Bellocci,M.,and Silvestrini,B.(1979).Morphological,histochemical and biochemicalstudies on germ cell mitochondria of normal rats.Cell and tissue research 196,1-22.9. De Martino, C., Floridi, A., Marcante, M.L., Malorni, W., Scorza Barcellona, P., Bellocci, M., and Silvestrini, B. (1979). Morphological, histochemical and biochemical studies on germ cell mitochondria of normal rats. Cell and tissue research 196, 1-22.
10.Enders,G.C.,and May,J.J.,2nd(1994).Developmentally regulated expression ofa mouse germ cell nuclear antigen examined from embryonic day 11 to adult in male andfemale mice.Developmental biology 163,331-340.10. Enders, G.C., and May, J.J., 2nd (1994). Developmentally regulated expression ofa mouse germ cell nuclear antigen examined from embryonic day 11 to adult in male and female mice. Developmental biology 163, 331-340.
11.Folgero,T.,Bertheussen,K.,Lindal,S.,Torbergsen,T.,and Oian,P.(1993).Mitochondrial disease and reduced sperm motility.Human reproduction 8,1863-1868.11. Folgero, T., Bertheussen, K., Lindal, S., Torbergsen, T., and Oian, P. (1993). Mitochondrial disease and reduced sperm motility. Human reproduction 8, 1863-1868.
12.Fontanesi,F.,Soto,I.C.,Horn,D.,and Barrientos,A.(2006).Assembly ofmitochondrial cytochrome c-oxidase,a complicated and highly regulated cellular process.American journal of physiology Cell physiology 291,C1129-1147.12. Fontanesi, F., Soto, I.C., Horn, D., and Barrientos, A. (2006). Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process. American journal of physiology Cell physiology 291-, C1129 1147.
13.Iadevaia,V.,Huo,Y.,Zhang,Z.,Foster,L.J.,and Proud,C.G.(2012).Rolesof the mammalian target of rapamycin,mTOR,in controlling ribosome biogenesis andprotein synthesis.Biochemical Society transactions 40,168-172.13. Iadevaia, V., Huo, Y., Zhang, Z., Foster, L.J., and Proud, C.G. (2012). Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis. Biochemical Society transactions 40, 168-172.
14.Kao,S.,Chao,H.T.,and Wei,Y.H.(1995).Mitochondrial deoxyribonucleic acid4977-bp deletion is associated with diminished fertility and motility of human sperm.Biology of reproduction 52,729-736.14. Kao, S., Chao, H.T., and Wei, Y.H.(1995). Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biology of reproduction 52, 729-736.
15.Koppen,M.,and Langer,T.(2007).Protein degradation within mitochondria:versatile activities of AAA proteases and other peptidases.Critical reviews in biochemistryand molecular biology 42,221-242.15. Koppen, M., and Langer, T. (2007). Protein degradation within mitochondria: versatile activities of AAA proteases and other peptides. Critical reviews in biochemistry and molecular biology 42, 221-242.
16.Lee,I.,and Suzuki,C.K.(2008).Functional mechanics of the ATP-dependent Lonprotease-lessons from endogenous protein and synthetic peptide substrates.Biochimica etbiophysica acta 1784,727-735.16. Lee, I., and Suzuki, C.K. (2008). Functional mechanics of the ATP-dependent Lonprotease-lessons from endogenous protein and synthetic peptide substrates. Biochimica etbiophysica acta 1784, 727-735.
17.Li,Y.C.,Hu,X.Q.,Zhang,K.Y.,Guo,J.,Hu,Z.Y.,Tao,S.X.,Xiao,L.J.,Wang,Q.Z.,Han,C.S.,and Liu,Y.X.(2006).Afaf,a novel vesicle membrane protein,is related to acrosome formation in murine testis.FEBS Lett 580,4266-4273.17. Li, Y.C., Hu, X.Q., Zhang, K.Y., Guo, J., Hu, Z.Y., Tao, S.X., Xiao, L.J., Wang, Q.Z., Han, C.S., and Liu, Y.X. (2006). Afaf, a novel vesicle membrane protein, is related to acrosome formation in murine testis. FEBS Lett 580, 4266-4273.
18.Luce,K.,Weil,A.C.,and Osiewacz,H.D.(2010).Mitochondrial protein qualitycontrol systems in aging and disease.Advances in experimental medicine and biology 694,108-125.18. Luce, K., Weil, A.C., and Osiewacz, H.D. (2010). Mitochondrial protein quality control systems in aging and disease. Advances in experimental medicine and biology 694, 108-125.
19.Meinhardt,A.,McFarlane,J.R.,Seitz,J.,and de Kretser,D.M.(2000).Activinmaintains the condensed type of mitochondria in germ cells.Molecular and cellularendocrinology 168,111-117.19. Meinhardt, A., McFarlane, J.R., Seitz, J., and de Kretser, D.M. (2000). Activin maintains the condensed type of mitochondria in germ cells. Molecular and cellular endocrinology 168, 111-117.
20.Metodiev,M.D.,Lesko,N.,Park,C.B.,Camara,Y.,Shi,Y.,Wibom,R.,Hultenby,K.,Gustafsson,C.M.,and Larsson,N.G.(2009).Methylation of 12S rRNA isnecessary for in vivo stability of the small subunit of the mammalian mitochondrialribosome.Cell metabolism 9,386-397.20. Metodiev, M.D., Lesko, N., Park, C.B., Camara, Y., Shi, Y., Wibom, R., Hultenby, K., Gustafsson, C.M., and Larsson, N.G. (2009). Methylation of 12S rRNA is necessary for in vivo stability of the small subunit of the mammalian mitochondrial ribosome. Cell metabolism 9, 386-397.
21.Mundy,A.J.,Ryder,T.A.,and Edmonds,D.K.(1995).Asthenozoospermia andthe human sperm mid-piece.Human reproduction 10,116-119.21. Mundy, A.J., Ryder, T.A., and Edmonds, D.K. (1995). Asthenozoospermia and the human sperm mid-piece. Human reproduction 10, 116-119.
22.Nakada,K.,Sato,A.,Yoshida,K.,Morita,T.,Tanaka,H.,Inoue,S.,Yonekawa,H.,and Hayashi,J.(2006).Mitochondria-related male infertility.Proceedingsof the National Academy of Sciences of the United States of America 103,15148-15153.22. Nakada, K., Sato, A., Yoshida, K., Morita, T., Tanaka, H., Inoue, S., Yonekawa, H., and Hayashi, J. (2006). Mitochondria-related male infertility. Proceedings of the National Academy of Sciences of the United States of America 103, 15148-15153.
23.Pan,Y.,and Shadel,G.S.(2009).Extension of chronological life span by reducedTOR signaling requires down-regulation of Sch9p and involves increased mitochondrialOXPHOS complex density.Aging 1,131-145.23. Pan, Y., and Shadel, G.S.(2009). Extension of chronological life span by reducedTOR signaling requires down-regulation of Sch9p and involves increased mitochondrialOXPHOS complex density. Aging 1, 131-145.
24.Piomboni,P.,Focarelli,R.,Stendardi,A.,Ferramosca,A.,and Zara,V.(2012).The role of mitochondria in energy production for human sperm motility.Int J Androl 35,109-124.24. Piomboni, P., Focarelli, R., Stendardi, A., Ferramosca, A., and Zara, V. (2012). The role of mitochondria in energy production for human sperm motility. Int J Androl 35, 109- 124.
25.Qin,Y.,Polacek,N.,Vesper,O.,Staub,E.,Einfeldt,E.,Wilson,D.N.,and Nierhaus,K.H.(2006).The highly conserved LepA is a ribosomal elongation factor thatback-translocates the ribosome.Cell 127,721-733.25. Qin, Y., Polacek, N., Vesper, O., Staub, E., Einfeldt, E., Wilson, D.N., and Nierhaus, K.H.(2006).The highly conserved LepA is a ribosomal elongation factor thatback- translocates the ribosome. Cell 127, 721-733.
26.Rajender,S.,Rahul,P.,and Mahdi,A.A.(2010).Mitochondria,spermatogenesisand male infertility.Mitochondrion 10,419-428.26. Rajender, S., Rahul, P., and Mahdi, A.A. (2010). Mitochondria, spermatogenesis and male infertility. Mitochondrion 10, 419-428.
27.Ramalho-Santos,J.,Varum,S.,Amaral,S.,Mota,P.C.,Sousa,A.P.,and Amaral,A.(2009).Mitochondrial functionality in reproduction:from gonads and gametes toembryos and embryonic stem cells.Hum Reprod Update 15,553-572.27. Ramalho-Santos, J., Varum, S., Amaral, S., Mota, P.C., Sousa, A.P., and Amaral, A. (2009). Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells .Hum Reprod Update 15, 553-572.
28.Reyes,J.G.,Farias,J.G.,Henriquez-Olavarrieta,S.,Madrid,E.,Parraga,M.,Zepeda,A.B.,and Moreno,R.D.(2012).The hypoxic testicle:physiology andpathophysiology.Oxidative medicine and cellular longevity 2012,929285.28. Reyes, J.G., Farias, J.G., Henriquez-Olavarrieta, S., Madrid, E., Parraga, M., Zepeda, A.B., and Moreno, R.D. (2012). The hypoxic testicle: physiology and pathophysiology. Oxidative medicine and cellular Longevity 2012, 929285.
29.Ruiz-Pesini,E.,Diez,C.,Lapena,A.C.,Perez-Martos,A.,Montoya,J.,Alvarez,E.,Arenas,J.,and Lopez-Perez,M.J.(1998).Correlation of sperm motility withmitochondrial enzymatic activities.Clinical chemistry 44,1616-1620.29. Ruiz-Pesini, E., Diez, C., Lapena, A.C., Perez-Martos, A., Montoya, J., Alvarez, E., Arenas, J., and Lopez-Perez, M.J. (1998). Correlation of sperm motility with mitochondrial enzymatic activities. Clinical chemistry 44, 1616-1620.
30.Savel'ev,A.S.,Novikova,L.A.,Kovaleva,I.E.,Luzikov,V.N.,Neupert,W.,and Langer,T.(1998).ATP-dependent proteolysis in mitochondria.m-AAA proteaseand PIM1 protease exert overlapping substrate specificities and cooperate with the mtHsp70system.The Journal of biological chemistry 273,20596-20602.30.Savel'ev, A.S., Novikova, L.A., Kovaleva, I.E., Luzikov, V.N., Neupert, W., and Langer, T. (1998).ATP-dependent proteolysis in mitochondria.m-AAA protease and PIM1 protease exert overlapping substrate specificities and cooperate with the mtHsp70system. The Journal of biological chemistry 273, 20596-20602.
31.Schieke,S.M.,Phillips,D.,McCoy,J.P.,Jr.,Aponte,A.M.,Shen,R.F.,Balaban,R.S.,and Finkel,T.(2006).The mammalian target of rapamycin(mTOR)pathwayregulates mitochondrial oxygen consumption and oxidative capacity.The Journal ofbiological chemistry 281,27643-27652.31. Schieke, S.M., Phillips, D., McCoy, J.P., Jr., Aponte, A.M., Shen, R.F., Balaban, R.S., and Finkel, T. (2006). The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. The Journal of biological chemistry 281, 27643-27652.
32.Shoji,S.,Janssen,B.D.,Hayes,C.S.,and Fredrick,K.(2010).Translation factorLepA contributes to tellurite resistance in Escherichia coli but plays no apparent role in thefidelity of protein synthesis.Biochimie 92,157-163.32. Shoji, S., Janssen, B.D., Hayes, C.S., and Fredrick, K. (2010). Translation factor LepA contributes to tellurite resistance in Escherichia coli but plays no apparent role in thefidelity of protein synthesis. Biochimie-92, 157 .
33.Smits,P.,Smeitink,J.,and van den Heuvel,L.(2010).Mitochondrial translationand beyond:processes implicated in combined oxidative phosphorylation deficiencies.Journal of biomedicine & biotechnology 2010,737385.33. Smits, P., Smeitink, J., and van den Heuvel, L. (2010). Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. Journal of biomedicine & biotechnology 2010, 737385.
34.Spiropoulos,J.,Turnbull,D.M.,and Chinnery,P.F.(2002).Can mitochondrial DNAmutations cause sperm dysfunction?Molecular human reproduction 8,719-721.34. Spiropoulos, J., Turnbull, D.M., and Chinnery, P.F. (2002). Can mitochondrial DNA mutations cause sperm dysfunction? Molecular human reproduction 8, 719-721.
35.St John,J.C.,Facucho-Oliveira,J.,Jiang,Y.,Kelly,R.,and Salah,R.(2010).Mitochondrial DNA transmission,replication and inheritance:a journey from the gametethrough the embryo and into offspring and embryonic stem cells.Hum Reprod Update 16,488-509.35. St John, J.C., Facucho-Oliveira, J., Jiang, Y., Kelly, R., and Salah, R. (2010). Mitochondrial DNA transmission, replication and inheritance: a journey from the gametethrough the embryo and into offspring and embryonic stem cells. Hum Reprod Update 16, 488-509.
36.Stiburek,L.,and Zeman,J.(2010).Assembly factors and ATP-dependent proteasesin cytochrome c oxidase biogenesis.Biochimica et biophysica acta 1797,1149-1158.36. Stiburek, L., and Zeman, J. (2010). Assembly factors and ATP-dependent proteases in cytochrome oxidase biogenesis. Biochimica et biophysica acta 1797, 1149-1158.
37.Suzuki,H.,Ueda,T.,Taguchi,H.,and Takeuchi,N.(2007).Chaperone propertiesof mammalian mitochondrial translation elongation factor Tu.The Journal of biologicalchemistry 282,4076-4084.37. Suzuki, H., Ueda, T., Taguchi, H., and Takeuchi, N. (2007). Chaperone properties of mammalian mitochondria translation elongation factor Tu. The Journal of biological chemistry 282, 4076-4084.
38.Tatsuta,T.(2009).Protein quality control in mitochondria.J Biochem 146,455-461.38. Tatsuta, T. (2009). Protein quality control in mitochondria. J Biochem 146, 455-461.
39.Thorrez,L.,Van Deun,K.,Tranchevent,L.C.,Van Lommel,L.,Engelen,K.,Marchal,K.,Moreau,Y.,Van Mechelen,I.,and Schuit,F.(2008).Using ribosomalprotein genes as reference:a tale of caution.PloS one 3,e1854.39. Thorrez, L., Van Deun, K., Tranchevent, L.C., Van Lommel, L., Engelen, K., Marchal, K., Moreau, Y., Van Mechelen, I., and Schuit, F. ( 2008). Using ribosomalprotein genes as reference: a tale of caution. PloS one 3, e1854.
40.Tiranti,V.,Corona,P.,Greco,M.,Taanman,J.W.,Carrara,F.,Lamantea,E.,Nijtmans,L.,Uziel,G.,and Zeviani,M.(2000).A novel frameshift mutation of themtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patientaffected by Leigh-like syndrome.Human molecular genetics 9,2733-2742.40. Tiranti, V., Corona, P., Greco, M., Taanman, J.W., Carrara, F., Lamantea, E., Nijtmans, L., Uziel, G., and Zeviani, M. (2000). A novel frameshift mutation of themtDNA COIII gene leads to impaired assembly of cytochrome oxidase in a patient affected by Leigh-like syndrome. Human molecular genetics 9, 2733-2742.
41.Tsukihara,T.,Aoyama,H.,Yamashita,E.,Tomizaki,T.,Yamaguchi,H.,Shinzawa-Itoh,K.,Nakashima,R.,Yaono,R.,and Yoshikawa,S.(1996).The wholestructure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A.Science 272,1136-1144.41. Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., and Yoshikawa, S. ( 1996). The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272, 1136-1144.
42.Wallace,D.C.(1999).Mitochondrial diseases in man and mouse.Science 283,1482-1488.42. Wallace, D.C. (1999). Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
43.Wang,X.,and Proud,C.G.(2006).The mTOR pathway in the control of proteinsynthesis.Physiology(Bethesda)21,362-369.43. Wang, X., and Proud, C.G. (2006). The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21, 362-369.
44.Wilson,K.S.,and Prochaska,L.J.(1990).Phospholipid vesicles containing bovineheart mitochondrial cytochrome c oxidase and subunit III-deficient enzyme:analysis ofrespiratory control and proton translocating activities.Archives of biochemistry andbiophysics 282,413-420.44.Wilson,K.S.,and Prochaska,L.J.(1990).Phospholipid vesicles containing bovineheart mitochondrial cytochrome c oxidase and subunit III-deficient enzyme:analysis ofrespiratory control and proton translocating activities.Archives of biochemistry andbiophysics 282,413-420.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310485227.5A CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310485227.5A CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103609526A CN103609526A (en) | 2014-03-05 |
CN103609526B true CN103609526B (en) | 2015-10-07 |
Family
ID=50160264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310485227.5A Active CN103609526B (en) | 2013-10-16 | 2013-10-16 | The application of mitochondrial protein translation factor Guf1 in male sterile research |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103609526B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110938652A (en) * | 2019-11-07 | 2020-03-31 | 浙江大学医学院附属第一医院 | Method and application of targeting vector and construction of F4/80-DTR transgenic mice that regulate and eliminate macrophages by diphtheria toxin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646562A (en) * | 2002-01-30 | 2005-07-27 | 爱丁堡大学 | Pluripotency determining factors and uses thereof |
CN101396564A (en) * | 2007-09-24 | 2009-04-01 | 中国科学院上海生命科学研究院 | Protein capable of adjusting sperm capacitation and use thereof |
CN101724612A (en) * | 2008-10-24 | 2010-06-09 | 李建远 | Human epididymis expression sperm binding protein HEL-128 as well as coding gene and application thereof |
CN101878747A (en) * | 2010-06-28 | 2010-11-10 | 中国人民解放军第四军医大学 | A method for constructing a mouse model of RdRp regulated expression and in vivo observation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4653915B2 (en) * | 2001-10-29 | 2011-03-16 | 独立行政法人科学技術振興機構 | Systemic lupus erythematosus model non-human animal |
US8203030B2 (en) * | 2007-09-05 | 2012-06-19 | The Regents Of The University Of California | Transgenic mouse models for diseases caused by mtDNA mutations and related methods |
-
2013
- 2013-10-16 CN CN201310485227.5A patent/CN103609526B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646562A (en) * | 2002-01-30 | 2005-07-27 | 爱丁堡大学 | Pluripotency determining factors and uses thereof |
CN101396564A (en) * | 2007-09-24 | 2009-04-01 | 中国科学院上海生命科学研究院 | Protein capable of adjusting sperm capacitation and use thereof |
CN101724612A (en) * | 2008-10-24 | 2010-06-09 | 李建远 | Human epididymis expression sperm binding protein HEL-128 as well as coding gene and application thereof |
CN101878747A (en) * | 2010-06-28 | 2010-11-10 | 中国人民解放军第四军医大学 | A method for constructing a mouse model of RdRp regulated expression and in vivo observation |
Non-Patent Citations (3)
Title |
---|
"ET克隆的引用及Resp18基因敲除小鼠模型的初步建立";杨建岭;《中国优秀硕士学位论文全文数据库基础科学辑》;20080415(第04期);第43-60页 * |
"Mitochondria, spermatogenesis and male infertility";Singh Rajender等;《Mitochondrion》;20100601;第10卷;第419-428页 * |
"The Membrane-bound GTPase Guf1 Promotes Mitochondrial Protein Synthesis under Suboptimal Conditions";Heike Bauerschmitt等;《The Journal of Biological Chemistry》;20080428;第283卷(第25期);第17139-17146页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103609526A (en) | 2014-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sha et al. | CNOT 6L couples the selective degradation of maternal transcripts to meiotic cell cycle progression in mouse oocyte | |
Abbasi et al. | RSPH6A is required for sperm flagellum formation and male fertility in mice | |
Neesen et al. | Disruption of an inner arm dynein heavy chain gene results in asthenozoospermia and reduced ciliary beat frequency | |
Tanaka et al. | Mice deficient in the axonemal protein Tektin-t exhibit male infertility and immotile-cilium syndrome due to impaired inner arm dynein function | |
Gutiérrez-Caballero et al. | Identification and molecular characterization of the mammalian α-kleisin RAD21L | |
Krähling et al. | CRIS—A novel cAMP-binding protein controlling spermiogenesis and the development of flagellar bending | |
Hu et al. | Epididymal cysteine-rich secretory proteins are required for epididymal sperm maturation and optimal sperm function | |
Quadalti et al. | SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype | |
Coˆté et al. | Comprehensive cross production system assessment of the impact of in vitro microenvironment on the expression of messengers and long non-coding RNAs in the bovine blastocyst | |
AU2018239433A1 (en) | A genetically modified mouse expressing human APOE4p and mouse Trem2 p.R47H and methods of use thereof | |
Dodd et al. | Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules | |
Mechaussier et al. | TUBB4B variants specifically impact ciliary function, causing a ciliopathic spectrum | |
Islam et al. | The RNA-binding protein Adad1 is necessary for germ cell maintenance and meiosis in zebrafish | |
Kaneda et al. | Testis‐specific proteins, TSNAXIP1 and 1700010I14RIK, are important for sperm motility and male fertility in mice | |
Wang et al. | ATP5D is a potential biomarker for male fertility | |
Xu et al. | CIB4 is essential for the haploid phase of spermatogenesis in mice | |
Philp et al. | Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) ablation limits offspring viability and growth in mice | |
Kashir et al. | The mammalian sperm factor phospholipase C zeta is critical for early embryo division and pregnancy in humans and mice | |
CN103609526B (en) | The application of mitochondrial protein translation factor Guf1 in male sterile research | |
Ru et al. | Maternal age enhances purifying selection on pathogenic mutations in complex I genes of mammalian mtDNA | |
Xia et al. | Testis-expressed protein 33 is not essential for spermiogenesis and fertility in mice | |
Toraason et al. | Aging and sperm signals alter DNA break formation and repair in the C. elegans germline | |
Teves et al. | Germ cell‐specific disruption of the Meig1 gene causes impaired spermiogenesis in mice | |
Cao et al. | BBOF1 is required for sperm motility and male fertility by stabilizing the flagellar axoneme in mice | |
Niu et al. | Mus musculus Barrier-To-Autointegration Factor 2 (Banf2) is Not Essential for Spermatogenesis or Fertility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |